5-Ht1b/1d Agonists (Triptans) has 3 known drug interactions based on U.S. FDA drug labeling data. Of these, 3 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Almotriptan, Sumatriptan, Zolmitriptan. Patients taking 5-Ht1b/1d Agonists (Triptans) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 3
Contraindicated: 3

Contraindicated (3)

5-Ht1b/1d Agonists (Triptans) + Almotriptan— Concomitant use within 24 hours is contraindicated.
5-Ht1b/1d Agonists (Triptans) + Sumatriptan— Coadministration of triptans with sumatriptan may have additive vasospastic effects. Use within 24 hours is contraindica…
5-Ht1b/1d Agonists (Triptans) + Zolmitriptan— Concomitant use of other 5-HT1B/1D agonists within 24 hours is contraindicated due to risk of additive vasospastic react…

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.